Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs140902451 | chr13:114160403 | G/GTCA | 4.56E-12 | 177 | 24.23 | 29.95 | 3.32 | KM Plot |
PCPG | rs140961092 | chr7:105149500 | A/G | 5.04E-5 | 178 | 20.17 | 28.95 | 2.28 | KM Plot |
PCPG | rs141094380 | chr20:10634658 | CA/C | 0.000208 | 172 | 24.37 | 34.83 | 14.28 | KM Plot |
PCPG | rs141136248 | chr16:89948948 | A/AAG | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |
PCPG | rs141155165 | chr5:50607395 | T/TA | 7.57E-5 | 174 | 25.28 | 24.62 | 31.35 | KM Plot |
PCPG | rs141269638 | chr11:18145067 | G/A | 3.28E-5 | 177 | 27.23 | 24.1 | 6.7 | KM Plot |
PCPG | rs141303458 | chr12:56698203 | T/TC | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs141321217 | chr3:115555528 | G/GAGATGT | 1.09E-5 | 176 | 25.2 | 26.37 | 13.75 | KM Plot |
PCPG | rs141332785 | chr2:118685214 | T/C | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs141347987 | chr16:71708483 | C/CA | 8.79E-6 | 175 | 24.23 | 31.48 | 14.5 | KM Plot |
PCPG | rs141382461 | chr22:25621485 | CA/C | 0.00017 | 175 | 25.28 | 28.3 | 60.48 | KM Plot |
PCPG | rs141443747 | chr16:89581343 | CTT/C | 0.000292 | 176 | 27.6 | 25.28 | 19.87 | KM Plot |
PCPG | rs141652077 | chr13:28241136 | GCTCC/G | 5.38E-6 | 178 | 25.17 | 26.57 | 11.78 | KM Plot |
PCPG | rs141671420 | chr8:121489334 | G/A | 4.28E-6 | 177 | 27.23 | 25.33 | 19.87 | KM Plot |
PCPG | rs141707414 | chr17:1410184 | CT/C | 1.46E-5 | 174 | 25.05 | 25 | 25.17 | KM Plot |